The Sema4 Network

Connecting | Sharing | Transforming


A Webcast Series Brought to you by Sema4


We are excited to present “The Sema4 Network” –
a live webcast series addressing our industry’s pressing topics.

Previously Aired Events

Topic: Join the Fight Against Pediatric Cancer: Leveraging Data to Transform Cancer Care for this Vulnerable Population


– Giselle Sholler, M.D. ISF Director Solid and Rare Tumor Program, Levine Children’s Hospital Chair, Beat Childhood Cancer Research Consortium
– Feras Hantash, PhD Vice President of Molecular Oncology at Sema4

Be part of the conversation as we invite world-renowned pediatric oncologist Dr. Giselle Sholler, the Director of the ISF Solid and Rare Tumor Program at Levine Children’s Hospital and Chair of the Beat Childhood Cancer consortium and, Sema4’s VP of Molecular Oncology, Dr. Feras Hantash as we discuss the advances in pediatric cancer care driven by the adoption of advanced genetic tests, real world data, and data science.  This webcast will cover the science behind clinical and genomic data analysis to guide treatment selection and other clinical decisions, highlight and review patient case studies, and identify key stakeholders needed to implement a differentiated precision oncology program.

For more information on the Beat Childhood Cancer Foundation, please click here.

Access webcast here

Headshot of Dr. Benjamin H. Lowentritt

Headshot of Dr. Neal Shore

Headshot of Dr. William Oh

Topic: Redefining Precision Oncology Prostate Cancer Care: Leveraging Data to Optimize Personalized Treatment


– Dr. Benjamin H. Lowentritt, M.D., F.A.C.S., Director, Prostate Cancer Care, Chesapeake Urology
– Dr. Neal D. Shore, M.D., F.A.C.S., U.S. Chief Medical Officer of Surgery and Oncology, GenesisCare USA
– Dr. William K. Oh, M.D., Chief Medical Science Officer, Sema4

In this webinar, you will be able to:

  • Learn about the differences between germline and somatic testing and their significance in identifying personalized prostate cancer treatment options
  • Learn about real-world case studies demonstrating how providers can utilize clinical and genomic data to inform on treatment decisions to enhance prostate cancer care
  • Gain knowledge of how to identify and implement strategies to leverage data to optimize personalized precision oncology treatment

Access webcast here

Topic: How to seamlessly and effectively switch your reproductive and hereditary cancer testing protocol and strategy to optimize your current clinical workflow


– Kristie N. Smith, MS, CGC – VP, Clinical Support, Education & Training

In this webinar, you will be able to: 

  • Differentiate among evidence-based testing solutions for women’s health
  • Leverage proactive genetic counseling as a value-add support for your practice
  • Integrate digital tools to maximize patient care

Access webcast here

Topic: Accelerating a Multidisciplinary Approach to Precision Medicine and Clinical Trials in the Community Oncology Setting


– Dr. Fred Ashbury, Ph.D., MACE, Chief Scientific Officer, VieCure
– Dr. Kashyap Patel, CEO, Carolina Blood and Cancer Care
– Sonia Gill, Director of Strategic Accounts, Sema4 (moderator)

Value-based care, the paradigm shift to genomic-guided treatments, increasing patient volumes, and workforce challenges are driving the need to provide community oncologists with innovative processes and tools to facilitate effective care delivery. Our panel addresses these critical issues while analyzing current gaps in utilizing precision medicine in community oncology. They also discuss the resources and innovative technologies required to develop an effective cancer delivery program and offer strategies to be successful in the community oncology setting for the coming decades.

Join Dr. Fred Ashbury of VieCure who also serves as Editor-in-Chief of Supportive Care in Cancer and Adjunct Professor at both the University of Toronto and the University of Calgary, and Dr. Kashyap Patel of Carolina Blood and Cancer Care who is also Associate Editor of Evidence-Based Oncology and Vice President of the Community Oncology Alliance on this important topic.

Access webcast here

Topic: Understanding Your Role in Hereditary Cancer Testing – Creating a New Standard of Care


– Elizabeth Etkin-Kramer, M.D., FACOG, Founder of Yodeah, Associate Professor in OBGYN at FIU Herbert Wertheim College of Medicine
– Kristie N. Smith, MS, CGC, Sr Director, Clinical Support, Education & Training, Sema4

Listen to Dr. Etkin-Kramer and Kristie as they discuss the overwhelming evidence that supports the importance of a patient ‘knowing their risk’. Obstetrician–gynecologists play a vital role in identifying and managing women at risk for hereditary cancer syndromes. Identification of high-risk women is vital to implement education, testing, personalized cancer early-detection and risk reduction measures to improve health and quality of life.

Dr. Etkin-Kramer discusses how she effectively implements a successful screening protocol and testing strategy into her clinical workflow. You will learn about Sema4’s evidence-based hereditary cancer testing solutions, genetic counseling support, and digital tools that can easily be integrated into your practice.

Webinar Disclaimer: The views expressed by speakers or other third parties in ACOG District XII webinars, events and/or conferences are those of the speaker or third-party and not, necessarily, of ACOG District XII.

Access webcast here

Topic: CATCHING CANCER EARLY: Assessing the need for and effectively implementing a care delivery model for hereditary cancer


– Matthew Lederman, M.D., Reproductive Endocrinologist and Infertility Specialist at RMA of New York
– Elizabeth Etkin-Kramer, M.D., FACOG, Associate Professor in OBGYN at FIU Herbert Wertheim College of Medicine
– Jill Chisholm, APNG President and Founder of GeneScreen and Chief Medical Officer of Synergenomics

Listen to the conversation held by Dr. Matthew Lederman, Dr. Elizabeth Etkin Kramer, and Jill Chisholm on the various considerations for, and the importance of, identifying those at risk for inherited cancer syndromes and how that necessitates updates to clinical management. This live panel discussion covered assessing risk through patient-provider engagement, integrating programs to complement protocols, and delivering results into physicians’ workflows to improve patient outcomes.

Learn about the most up to date clinical guidelines here: ACOG Hereditary Cancer Syndromes and Risk Assessment

Access webcast here

Topic: Essential Strategies for Providers and Physician Groups to Implement and Engage on Telehealth


– David Bellaire, Executive Adviser and former Chair of the Board of Directors at Sema4
– Dr. Shayan Vyas, VP of Clinical Operations and Medical Director at Teladoc Health
– Dr. Stella M. Dantas, Obstetrician & Gynecologist, Assoc. Med Director, Ambulatory & Convenient Care at Kaiser Permanente

Telehealth has become significantly more important since the COVID-19 outbreak. Tune in to our recent webcast for an insightful and engaging conversation with two healthcare thought leaders in the field of telehealth. Sema4’s David Bellaire interviews Dr. Vyas from Teladoc Health, an industry leading virtual care services provider, and Dr. Dantas from Kaiser Permanente Northwest, a progressive health system that has successfully implemented telehealth. In this live and interactive discussion, the group covers how to get started with virtual care, essential technology to make it a success, and the aspects of care that are most conducive to telehealth.

Access webcast here

Topic: Impact of COVID-19 on Gamete Donor Collection

Speakers: Dr. Alan Copperman, Sema4 Chief Medical Officer – Reproductive Health and Dr. Jaime Shamonki, Generate Life Sciences Chief Medical Officer

Watch a conversation between two industry experts in the field of reproductive donor tissue. Dr. Copperman interviews Dr. Shamonki about the impact of COVID-19 on gamete donor collection, what we know about the spread of COVID-19 through tissue, and studies that will be needed post-COVID to better understand the effect on reproductive medicine and donor bank policies.

Access the webcast here

Topic: The Virtual Patient Experience: Embracing an on-demand style of digital care, while leveraging patient data to make more informed clinical decisions.

Speaker: Tony Prentice, Sema4’s Chief Product Officer

Our CPO, Tony Prentice, discusses how to deliver on participatory healthcare and the importance of cross-platform tools, seamless test consenting, convenient care and enhanced patient engagement in the COVID-19 era.

Access the webcast here

Topic: Navigating a Safe Return to Reproductive Care: Reopening IVF Centers During COVID-19

Speaker: Dr. Alan Copperman, Sema4 Chief Medical Officer – Reproductive Health

Dr. Copperman discusses the measures IVF clinics are taking to engage and support staff during the current pandemic, and how IVF clinics can adjust their practices to optimize patient and health care worker safety.

Access the webcast here

Topic: The Seismic Shift: COVID-19, Testing and The Digital Health Revolution

Speaker: Dr. Eric Schadt, Sema4 Founder and CEO

The first edition of our live webcast series, The Sema4 Network, aired on April 17th, 2020. Dr. Eric Schadt, Sema4 Founder and CEO, discussed the global landscape of the COVID-19 pandemic and how Sema4 is helping to alleviate the burden by developing a COVID-19 test.

Access the webcast here


Stay Connected

Fill out the form below to get notified of upcoming events.